Literature DB >> 15371946

Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases.

Ingrid M Rodriguez1, Julie A Irving, Jaime Prat.   

Abstract

Ovarian mucinous borderline tumors are divided into two morphologic groups: endocervical-like and intestinal type, the latter comprising the majority of cases. Thirty-one endocervical-like ovarian mucinous borderline tumors (ELMBTs) were reviewed and evaluated for the presence of intraepithelial carcinoma and microinvasion. Intraepithelial carcinoma was identified in 13% and stromal microinvasion in 23% of cases. All but 1 patient were stage I. Follow-up information was available for 21 patients; all were alive with no evidence of disease at a mean follow-up interval of 5.7 years. Six of 8 patients with ELMBT containing foci of microinvasion and/or intraepithelial carcinoma and for whom follow-up was available were alive with no evidence of disease at a mean follow-up interval of 6.6 years. These results indicate that ELMBTs, specifically those exhibiting intraepithelial carcinoma and microinvasion, are tumors associated with an excellent prognosis. The frequency of occurrence and criteria for the diagnosis of intraepithelial carcinoma and microinvasion in ELMBT are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15371946     DOI: 10.1097/01.pas.0000138178.10829.b8

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors.

Authors:  Taira Hada; Morikazu Miyamoto; Hiroki Ishibashi; Haruka Kawauchi; Hiroaki Soyama; Hiroko Matsuura; Takahiro Sakamoto; Soichiro Kakimoto; Tadashi Aoyama; Hideki Iwahashi; Rie Suzuki; Hitoshi Tsuda; Masashi Takano
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Adhering to the 2014 WHO terminology on borderline ovarian tumors.

Authors:  Jaime Prat
Journal:  Virchows Arch       Date:  2017-02       Impact factor: 4.064

Review 3.  Diagnosis, treatment, and follow-up of borderline ovarian tumors.

Authors:  Daniela Fischerova; Michal Zikan; Pavel Dundr; David Cibula
Journal:  Oncologist       Date:  2012-09-28

4.  Tumor-infiltrating neutrophils in pancreatic neoplasia.

Authors:  Michelle D Reid; Olca Basturk; Duangpen Thirabanjasak; Ralpha H Hruban; David S Klimstra; Pelin Bagci; Deniz Altinel; Volkan Adsay
Journal:  Mod Pathol       Date:  2011-08-05       Impact factor: 7.842

Review 5.  [Mucinous ovarian neoplasms. Prognostically mostly excellent, infrequently a wolf in sheep's clothing].

Authors:  S Lax; A Staebler
Journal:  Pathologe       Date:  2014-07       Impact factor: 1.011

Review 6.  Recent concepts of ovarian carcinogenesis: type I and type II.

Authors:  Masafumi Koshiyama; Noriomi Matsumura; Ikuo Konishi
Journal:  Biomed Res Int       Date:  2014-04-23       Impact factor: 3.411

Review 7.  Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria.

Authors:  Steffen Hauptmann; Katrin Friedrich; Raymond Redline; Stefanie Avril
Journal:  Virchows Arch       Date:  2016-12-27       Impact factor: 4.064

Review 8.  Ovarian Seromucinous Tumors: Pathogenesis, Morphologic Spectrum, and Clinical Issues.

Authors:  Michiko Nagamine; Yoshiki Mikami
Journal:  Diagnostics (Basel)       Date:  2020-01-31

9.  Uncommon borderline ovarian tumours: A clinicopathologic study of seventeen patients

Authors:  Dilek Yüksel; Caner Çakır; Günsu Kimyon Cömert; Çiğdem Kılıç; Yasin Durmuş; Nurettin Boran; Gökhan Boyraz; Alper Karalök; Taner Turan
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-09-04

10.  Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.

Authors:  Yasuhisa Kurata; Aki Kido; Yusaku Moribata; Kyoko Kameyama; Sachiko Minamiguchi; Ikuo Konishi; Kaori Togashi
Journal:  Magn Reson Med Sci       Date:  2017-10-06       Impact factor: 2.471

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.